14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $1.91 $2.71 Wednesday, 24th Apr 2024 CANF stock ended at $1.94. This is 1.52% less than the trading day before Tuesday, 23rd Apr 2024. During the day the stock fluctuated 1.03% from a day low at $1.94 to a day high of $1.96.
90 days $1.91 $2.71
52 weeks $1.71 $3.33

Historical Can-Fite BioPharma Ltd prices

Date Open High Low Close Volume
Aug 14, 2023 $2.71 $2.73 $2.63 $2.67 5 265
Aug 11, 2023 $2.74 $2.79 $2.62 $2.71 16 717
Aug 10, 2023 $2.80 $2.80 $2.72 $2.78 4 187
Aug 09, 2023 $2.80 $2.83 $2.79 $2.83 4 857
Aug 08, 2023 $2.90 $2.90 $2.70 $2.79 9 703
Aug 07, 2023 $3.05 $3.00 $2.88 $2.91 5 804
Aug 04, 2023 $2.93 $3.04 $2.93 $2.95 4 635
Aug 03, 2023 $3.04 $2.99 $2.92 $2.97 5 399
Aug 02, 2023 $3.08 $3.07 $2.90 $2.90 9 833
Aug 01, 2023 $3.02 $3.09 $3.02 $3.03 7 989
Jul 31, 2023 $3.04 $3.06 $2.96 $3.02 12 156
Jul 28, 2023 $3.00 $3.09 $2.82 $3.09 33 861
Jul 27, 2023 $2.91 $3.00 $2.91 $2.95 14 764
Jul 26, 2023 $3.02 $3.02 $2.91 $2.93 6 624
Jul 25, 2023 $3.01 $3.04 $2.94 $2.94 18 850
Jul 24, 2023 $3.00 $3.06 $3.00 $3.03 10 039
Jul 21, 2023 $3.17 $3.16 $3.00 $3.00 14 299
Jul 20, 2023 $3.16 $3.13 $3.07 $3.07 5 905
Jul 19, 2023 $3.19 $3.14 $3.10 $3.12 13 036
Jul 18, 2023 $3.05 $3.12 $3.07 $3.12 5 238
Jul 17, 2023 $3.10 $3.18 $3.09 $3.11 10 092
Jul 14, 2023 $2.99 $3.09 $2.99 $3.04 5 350
Jul 13, 2023 $2.98 $3.10 $3.00 $3.01 14 071
Jul 12, 2023 $3.10 $3.10 $2.97 $2.98 3 688
Jul 11, 2023 $3.00 $3.07 $3.00 $3.00 8 564
Click to get the best stock tips daily for free!

About Can-Fite BioPharma Ltd

Can-Fite BioPharma Ltd Can-Fite BioPharma Ltd., a clinical-stage biopharmaceutical company, develops small molecule therapeutic products for the treatment of cancer, liver inflammatory diseases, and erectile dysfunction. The company's lead drug candidate Piclidenoson, which has been completed Phase III clinical trial for the treatment of psoriasis; and Phase II clinical trial for the treatment of COVID-19. It also develops Namodenoson that is in Phase III clinical tria... CANF Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT